Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 501–600 of 1,000
Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals
Ganetsky, V. S., Krawczyk, N., & Kennedy‐Hendricks, A. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.6069 · Cited by 11
Saunders, C., King, T. L., Smith, S., Buchheit, J. Q., Cook, K., Edds, J., & Mefford, L. C. (2014) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000049 · Cited by 11
Baldo, B. A. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03563-8 · Cited by 11
Dwivedi, I., & Haddad, G. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1403326 · Cited by 11
Neonatal Abstinence Syndrome: Twelve Years of Experience at a Regional Referral Center
Mücke, S., Nagel, M., Siedentopf, J.-P., Bührer, C., & Hüseman, D. (2016) · Klinische Pädiatrie · doi:10.1055/s-0042-115300 · Cited by 11
A Review of Neurobehavioral Challenges in Children Exposed Prenatally to Intrauterine Opioid
Alaedini, K., Haddadi, K., & Asadian, L. (2017) · Journal of Pediatrics Review · doi:10.5812/jpr.9234 · Cited by 11
Griffiths, S., Campbell, D. M., Caudarella, A., Guimond, T. H., Lamba, W., Lurie, E., Nader, M., Sgro, M. D., & Turner, S. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000776 · Cited by 11
Gabrhelík, R., Handal, M., Mravčík, V., Nechanská, B., Tjagvad, C., Thylstrup, B., Hesse, M., Minařík, J., Jarkovský, J., Bukten, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047028 · Cited by 11
Neonatal Opioid Withdrawal Syndrome Is Associated With Infant Foster Care Entry At The County Level
Loch, S. F., Stein, B. D., Ghertner, R., McNeer, E. A., Dupont, W. D., Smart, R., & Patrick, S. W. (2021) · Health Affairs · doi:10.1377/hlthaff.2021.00460 · Cited by 11
Risk Factors Associated with Perinatal Relapse to Opioid Use Disorder
Nawaz, N., Hester, M., Oji‐Mmuo, C. N., Pomar, E. M. G., & Allen, A. M. (2022) · NeoReviews · doi:10.1542/neo.23-5-e291 · Cited by 11
Global research production in neonatal abstinence syndrome: A bibliometric analysis
Zyoud, S. H., Al‐Jabi, S. W., Shahwan, M. J., & Jairoun, A. A. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i3.307 · Cited by 11
Pharmacologic Treatment of Opioid Addiction During Pregnancy
Keough, L., & Fantasia, H. C. (2017) · Nursing for Women s Health · doi:10.1016/j.nwh.2016.12.010 · Cited by 11
Lai, A., Philpot, P., Boucher, J., & Meyer, A. D. J. (2017) · Population Health Management · doi:10.1089/pop.2016.0192 · Cited by 11
Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome
Miller, J. S., Erwin, P. C., Davis, S. K., Anderson, J. G., & Lindley, L. C. (2019) · Policy Politics & Nursing Practice · doi:10.1177/1527154419864540 · Cited by 11
High-Risk Pregnancy: Management Options
Wildschut, H. I. J., Duvekot, J. J., Cook, J. R., Bacchus, L. J., Bewley, S., Creighton, S., Dear, J., Williams, D., Kilby, M. D., Crouch, N. S., et al. (2017) · Cambridge University Press eBooks · doi:10.1017/9781108349185 · Cited by 11
Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome
Gaither, J. R., Drago, M. J., Grossman, M. R., Li, Y., Shabanova, V., Xu, X. J., & Leventhal, J. M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.35074 · Cited by 10
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy
Perry, B. N., Vais, S., Boateng, J. O., Jain, M., Wachman, E. M., & Saia, K. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001004 · Cited by 10
Intrauterine and Neonatal Exposure to Opioids: Toxicological, Clinical, and Medico-Legal Issues
Albano, G. D., Spina, C. L., Pitingaro, W., Milazzo, V., Triolo, V., Argo, A., Malta, G., & Zerbo, S. (2023) · Toxics · doi:10.3390/toxics11010062 · Cited by 10
Czynski, A. J., Laptook, A. R., Das, A., Smith, B., Simon, A. E., Greenberg, R. G., Annett, R. D., Lee, J. Y., Snowden, J. N., Pedroza, C., et al. (2023) · Trials · doi:10.1186/s13063-023-07378-x · Cited by 10
Fryer, K. E., Reid, C. N., Elmore, A. L., Mehra, S., Carr, C., Salemi, J. L., Cogle, C. R., Pelletier, C., Garrillo, M. P., Sappenfield, W. M., et al. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005315 · Cited by 10
Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches
Singh, R., Melvin, P. R., Wachman, E. M., Rothstein, R., Schiff, D. M., Murzycki, J., VanVleet, M. W., Gupta, M., Davis, J. M., & Massachusetts, P. C. O. (2024) · Journal of Perinatology · doi:10.1038/s41372-024-01953-z · Cited by 10
He, Y., Chaiyachati, B. H., Matone, M., Bastos, S., Kallem, S., Mehta, A. D., & Wood, J. N. (2024) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2024.106798 · Cited by 10
Seghete, K. L. M., Graham, A. M., Shank, T. M., Alsup, S., Fisher, P. A., Wilson, A. C., & Ewing, S. W. F. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00296-x · Cited by 10
Emerging therapies for the treatment of neonatal abstinence syndrome
Frazier, L. M., Bobby, L., & Gawronski, K. M. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1733522 · Cited by 10
A Review of Feeding Practices in Infants With Neonatal Abstinence Syndrome
Taylor, K., & Maguire, D. J. (2020) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000780 · Cited by 10
Tabi, S., Heitner, S. A., Shivale, S., Minchenberg, S. B., Faraone, S. V., & Johnson, B. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.563409 · Cited by 10
Sujan, A. C., Cleary, E. N., Douglas, E., Aujla, R., Boyars, L., Smith, C., & Guille, C. (2021) · Family Practice · doi:10.1093/fampra/cmab121 · Cited by 10
Cutler, A. J., Cox, D. F., Gabrielson, S. M. B., Picarillo, A. P., & Craig, A. K. (2022) · Journal of Perinatology · doi:10.1038/s41372-022-01579-z · Cited by 11
Myers, A. M., Bowen, S. E., & Brummelte, S. (2023) · Developmental Psychobiology · doi:10.1002/dev.22433 · Cited by 10
Fetal Surveillance in Late Pregnancy and During Labor
Izquierdo, L. A., & Yonke, N. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.009 · Cited by 10
Opioid treatment of opioid addiction
McDonough, M. (2013) · Australian Prescriber · doi:10.18773/austprescr.2013.033 · Cited by 10
Wachman, E. M., Hunter, R. G., Shrestha, H., Lapp, H. E., Meyer, J. S., Alvarez, C., & Tronick, E. Z. (2019) · Developmental Psychobiology · doi:10.1002/dev.21896 · Cited by 10
Methadone versus morphine treatment outcomes in neonatal abstinence syndrome: A meta‐analysis
Xiao, F., Yan, K., & Zhou, W. (2019) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.14609 · Cited by 10
Hignell, A., Carlyle, K., Bishop, C., Murphy, M., Valenzano, T. J., Turner, S., & Sgro, M. D. (2019) · Paediatrics & Child Health · doi:10.1093/pch/pxz127 · Cited by 10
Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder
Robin, A. M., Hersh, A. R., John, C. S., & Caughey, A. B. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1873266 · Cited by 10
Lin, C.-H., Tao, P., Tsay, H.-J., Chiang, Y., Chang, W.-T., Ho, I. K., & Shie, F. (2021) · Behavioural Neurology · doi:10.1155/2021/6301458 · Cited by 10
Soyka, M., Backmund, M., Schmidt, P., & Apelt, S. M. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12131.x · Cited by 10
Characteristics and quality of life of opioid-dependent pregnant women in Austria
Metz, V. E., Comer, S. D., Würzl, J., Pribasnig, A., & Fischer, G. (2014) · Archives of Women s Mental Health · doi:10.1007/s00737-014-0443-6 · Cited by 10
Self-citationClinical Management of the Breast-Feeding Mother–Infant Dyad in Recovery From Opioid Dependence
Busch, D. W. (2016) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000117 · Cited by 10
Quantitation of Total Buprenorphine and Norbuprenorphine in Meconium by LC-MS/MS
Marin, S. J., & McMillin, G. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3252-8_7 · Cited by 10
Miller, J. S., Anderson, J. G., & Lindley, L. C. (2020) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/jcap.12273 · Cited by 10
Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period
Oji‐Mmuo, C. N., Jones, A. N., Wu, E. Y., Speer, R. R., & Palmer, T. W. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106978 · Cited by 9
Christianson, H. L., Sabry, A. A., Sous, J. E. G., Adams, J. H., Hoppe, K. K., & Antony, K. M. (2021) · Reproductive Medicine · doi:10.3390/reprodmed2040019 · Cited by 9
Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
Koltenyuk, V., Mrad, I., Choe, I., Ayoub, M. I., Kumaraswami, S., & Xu, J. L. (2024) · Journal of Pain Research · doi:10.2147/jpr.s434010 · Cited by 9
Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence
Flores, A., Nguyen, N. M., Devanaboyina, M., Sanketh, S., Athota, P., Sankarasubramanian, J., Guda, C., Yelamanchili, S. V., & Pendyala, G. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10129-7 · Cited by 9
Psychotropic medication use during pregnancy
Niethe, M., & Whitfield, K. (2018) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1483 · Cited by 9
Amplitude-integrated EEG in infants with neonatal abstinence syndrome
Rana, D. B., Pollard, L., Rowland, J., Dhanireddy, R., & Pourcyrous, M. (2019) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-1834 · Cited by 9
Buprenorphine X-waiver exemption – beyond the basics for the obstetrical provider
Cleary, E. M., Smid, M. C., Charles, J. E., Jones, K. M., Costantine, M. M., Saade, G. R., & Rood, K. M. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100451 · Cited by 9
Allen, M. C., Moog, N. K., Buß, C., Yen, E., Gustafsson, H., Sullivan, E. L., & Graham, A. M. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.107033 · Cited by 9
Mills-Huffnagle, S. L., & Nyland, J. E. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067883 · Cited by 9
L-NAC and L-NAC methyl ester prevent and overcome physical dependence to fentanyl in male rats
Bates, J. N., Baby, S. M., Getsy, P. M., Coffee, G. A., Hsieh, Y., Knauss, Z. T., Dahan, A., Bubier, J. A., MacFarlane, P. M., Mueller, D. T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59551-0 · Cited by 9
Clinical Guidelines for Opioid Substitution Treatment
(2016) · Lenus, The Irish Health Repository (Dr Steevens Hospital Library) · Cited by 9
Maternal Methadone Treatment and Neonatal Abstinence Syndrome
Singh, K., Faisal, M., Li, S., & Liu, W. (2015) · American Journal of Perinatology · doi:10.1055/s-0035-1549218 · Cited by 9
Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice
Oberdick, J., Ling, Y., Phelps, M. A., Yudovich, M., Schilling, K., & Sadée, W. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.231902 · Cited by 9
Giles, A. C., Ren, D., & Founds, S. A. (2016) · Nursing for Women s Health · doi:10.1016/j.nwh.2016.04.024 · Cited by 9
Zhao, L., Cheng, C., & Bouchard, L. T. (2020) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000744 · Cited by 9
Fudin, H. R., Babin, J. L., Hong, L. T., Ku, J., May, A. L., Wisner, A. S., Hall, F. S., & Ray, S. D. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.08.015 · Cited by 9
Goodman, D. (2011) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2011.00049.x · Cited by 9
Fernandez, S., Bruni, T., Bishop, L., Turuba, R., Olibris, B., & Jumah, N. A. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy091 · Cited by 9
Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy
Newman, R. G., & Gevertz, S. G. (2011) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.609806 · Cited by 9
Neonatal Outcomes after Use of Buprenorphine during Pregnancy
Krans, E. E. (2022) · New England Journal of Medicine · doi:10.1056/nejme2212967 · Cited by 9
Burduli, E., & Jones, H. E. (2024) · Seminars in Perinatology · doi:10.1016/j.semperi.2024.152010 · Cited by 8
Self-citationMonthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy
Ramage, M., Bishop, B., Mangano, V., & Mankabady, B. (2025) · American Journal on Addictions · doi:10.1111/ajad.70034 · Cited by 8
Proxy Finnegan Component Scores for Eat, Sleep, Console in a Cohort of Opioid-Exposed Neonates
Curran, M., Holt, C. T., Arciero, M., Quinlan, J., Cox, D., & Craig, A. K. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2020-0190 · Cited by 8
Impact of Adolescent Nicotine Exposure in Pre- and Post-natal Oxycodone Exposed Offspring
Flores, A., Gowen, A. M., Schaal, V. L., Koul, S., Hernandez, J. B., Yelamanchili, S. V., & Pendyala, G. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10074-x · Cited by 8
Kelty, E. A., Cumming, C., & Preen, D. B. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2678 · Cited by 8
Neonatal Morbidities of Prenatal and Perinatal Origin
Greenberg, J. M., Narendran, V., Schibler, K. R., Warner, B. B., Haberman, B. E., & Donovan, E. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50061-2 · Cited by 8
Neonatal abstinence syndrome and neurodevelopmental health outcomes: A state of the science
Miller, J. S., Davis, S. K., Erwin, P. C., Anderson, J. G., & Lindley, L. C. (2018) · Journal of Neonatal Nursing · doi:10.1016/j.jnn.2018.06.002 · Cited by 8
Pharmacologic Therapy for Neonatal Abstinence Syndrome
Kocherlakota, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54391-0.00019-9 · Cited by 8
Handal, M., Nechanská, B., Skurtveit, S. O., Lund, I. O., Gabrhelík, R., Engeland, A., & Mravčík, V. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.501 · Cited by 8
Burduli, E., Smith, C. L., Tham, P., Shogan, M., Johnson, R. K., & McPherson, S. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100494 · Cited by 8
Staszewski, C. L., Garretto, D. J., Garry, E., Ly, V. V., Davis, J. A., & Herrera, K. M. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0106 · Cited by 8
Galvin, S. L., Ramage, M., Mazure, E. S., & Coulson, C. C. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108098 · Cited by 8
Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments
Ward, C., & CHRISTENSEN, C. W. (2020) · American Journal of Perinatology Reports · doi:10.1055/s-0040-1713787 · Cited by 8
Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model
Safa, A., Lau, A. R., Aten, S., Schilling, K., Bales, K. L., Miller, V. A., Fitzgerald, J., Chen, M., Hill, K. L., Dzwigalski, K. R., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.613328 · Cited by 8
Decesare, J. Z. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.029 · Cited by 8
Management of Substance Abuse in Pregnancy: Maternal and Neonatal Aspects
Brandt, L., Leifheit, A. K., Finnegan, L. P., & Fischer, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-54562-7_12 · Cited by 8
Self-citationTreating Neonatal Abstinence Syndrome from Clinical Perspectives
Nayeri, F., Ebrahim, B., Shariat, M., Dalili, H., Kalani, M., Karbasian, N., & Sheikh, M. (2017) · Iranian Journal of Pediatrics · doi:10.5812/ijp.6266 · Cited by 8
Sugarman, D. E., Reilly, M. E., & Greenfield, S. F. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0172-9 · Cited by 8
Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders
Jacobs, A., & Cangiano, M. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.08.002 · Cited by 8
Taleghani, A. A., Isemann, B. T., Rice, W. R., Ward, L. P., Wedig, K. E., & Akinbi, H. T. (2019) · Paediatric and Neonatal Pain · doi:10.1002/pne2.12008 · Cited by 8
Bloch‐Salisbury, E., Bogen, D. L., Vining, M. A., Netherton, D., Rodríguez, N., Bruch, T., Burns, C., Erceg, E., Glidden, B., Ayturk, D., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100737 · Cited by 8
The comparative safety of buprenorphine versus methadone in pregnancy—what about confounding?
Brogly, S. B., Saia, K., Hernández–Díaz, S., Werler, M. M., & Sebastiani, P. (2016) · Addiction · doi:10.1111/add.13551 · Cited by 8
Brief Report: Pregnancy intention and opioid use disorder treatment retention in the MOTHER study
Martin, C. E., Terplan, M., O’Grady, K. E., & Jones, H. E. (2018) · American Journal on Addictions · doi:10.1111/ajad.12735 · Cited by 8
Self-citationImproving maintenance treatment of opiate addiction: Clinical aspects
Simojoki, K. (2013) · Helda - University of Helsinki Institutional Repository · Cited by 8
Bandstra, E. S. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04059.x · Cited by 8
Mehrpour, O., Nakhaee, S., Abdollahi, J., & Vohra, V. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-024-05957-x · Cited by 7
Martin, S., Parlier‐Ahmad, A. B., Eglovitch, M., Ondersma, S. J., Svikis, D. S., & Martin, C. E. (2022) · Women s Health Reports · doi:10.1089/whr.2022.0046 · Cited by 7
Pharmacotherapy for opioid use disorder in pregnancy
Trammel, C. J., Whitley, J., & Kelly, J. C. (2024) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000932 · Cited by 7
Knittel, A. K., Swartzwelder, R. A., Zarnick, S., Tsujimoto, T. H. M., Horne, T., Lin, F. C., Edwards, J., Amos, E., Alexander, J. M., Thorp, J. M., et al. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001184 · Cited by 7
Self-citationA population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy
Schmidt, R. A., Everett, K., Perez‐Brumer, A., Strıke, C., Rush, B. R., & Gomes, T. (2024) · Addiction · doi:10.1111/add.16459 · Cited by 7
Lipophilic analogues of D-cysteine prevent and reverse physical dependence to fentanyl in male rats
Bates, J. N., Getsy, P. M., Coffee, G. A., Baby, S. M., MacFarlane, P. M., Hsieh, Y., Knauss, Z. T., Bubier, J. A., Mueller, D. T., & Lewis, S. J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1336440 · Cited by 7
A woman's experience of tapering from buprenorphine during pregnancy
Welle-Strand, G. K., Kvamme, O., Andreassen, A., & Ravndal, E. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-207207 · Cited by 7
Xu, X. J., Yonkers, K. A., & Ruger, J. P. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1260-5 · Cited by 7
Addictive Disorders in Women: The Impact of Maternal Substance Use on the Fetus and Newborn
Oji‐Mmuo, C. N., Corr, T. E., & Doheny, K. K. (2017) · NeoReviews · doi:10.1542/neo.18-10-e576 · Cited by 8
Passive Addiction and Teratogenic Effects
Woodward, L. J., McPherson, C. C., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00038-7 · Cited by 7
Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome
Townsel, C., Covault, J., Hussain, N., Oncken, C. A., Nold, C., & Campbell, W. A. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1612870 · Cited by 7
Scott, L. F., Guilfoy, V., Duwve, J. M., & Rawl, S. M. (2020) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000772 · Cited by 7
Caring for Pregnant and Parenting Women with Opioid Use Disorder
Terplan, M., Martin, C. E., Premkumar, A., & Krans, E. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_14 · Cited by 7
Medicaid prevalence and opioid use disorder treatment access disparities
Richards, M. R., Leech, A. A., Stein, B. D., Buntin, M. B., & Patrick, S. W. (2021) · Health Services Research · doi:10.1111/1475-6773.13920 · Cited by 7
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.